SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-009310
Filing Date
2019-05-09
Accepted
2019-05-09 16:22:15
Documents
64
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q sphs20190331_10q.htm 10-Q 919932
2 EXHIBIT 10.1 ex_143547.htm EX-10.1 245669
3 EXHIBIT 31.1 ex_143209.htm EX-31.1 11148
4 EXHIBIT 31.2 ex_143206.htm EX-31.2 12261
5 EXHIBIT 32.1 ex_143207.htm EX-32.1 6715
6 EXHIBIT 32.2 ex_143208.htm EX-32.2 7035
  Complete submission text file 0001437749-19-009310.txt   3995944

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT sphs-20190331.xml EX-101.INS 668684
8 XBRL TAXONOMY EXTENSION SCHEMA sphs-20190331.xsd EX-101.SCH 45965
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sphs-20190331_cal.xml EX-101.CAL 34053
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sphs-20190331_def.xml EX-101.DEF 272607
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE sphs-20190331_lab.xml EX-101.LAB 226011
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sphs-20190331_pre.xml EX-101.PRE 295617
Mailing Address 1258 PROSPECT STREET LA JOLLA CA 92037
Business Address 1258 PROSPECT STREET LA JOLLA CA 92037 858-777-1760
SOPHIRIS BIO INC. (Filer) CIK: 0001563855 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36054 | Film No.: 19810885
SIC: 2834 Pharmaceutical Preparations